Author Archive for: aaronm23@mitash.com

A recent double-blind, placebo-controlled trial tested the efficacy of adjunctive rosiglitazone treatment alongside standard antimalarial care in Mozambican children with severe malaria. The findings were published in International Journal of Infectious Diseases. The study comprised 180 children and examined if rosiglitazone, a medication commonly used in diabetes management, could impact the levels of circulating angiopoietin-2 […]

The HbA1c test is a vital tool in diabetes management, measuring average blood sugar levels over several months. Contrary to the common myth that being prediabetic or at the borderline of diabetes is insignificant, it’s crucial to understand the importance of proactive measures even at this stage. Prediabetes indicates elevated blood sugar levels that haven’t […]

New York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA) for its anti-tissue factor pathway inhibitor (anti-TFPI) candidate marstacimab for individuals living with hemophilia A or hemophilia B without inhibitors to Factor VIII (FVIII) or Factor IX (FIX). The European marketing authorization application (MAA) for […]

USA: A recent study published in the Journal of Esthetic and Restorative Dentistry has shed light on the isolated effect of filler particle size on surface properties of experimental resin composites before and after toothbrush abrasion. The researchers showed a significant reduction in gloss of resin-based composites (RBCs) containing fillers with larger particle sizes. There […]

A landmark study has shown that severe asthma can be controlled using biologic therapies, without the addition of regular high-dose inhaled steroids which can have significant side effects. The findings from the multinational SHAMAL study, published in The Lancet, demonstrated that 92% of patients using the biologic therapy benralizumab could safely reduce inhaled steroid dose […]